Jan 26 2024
Here is a transcript of an interview with Christian T. Ruff, MD, Senior Investigator, Thrombolysis in Myocardial Infarction (TIMI) Study Group, Boston, Massachusetts,USA describing the favorable AZALEA-TIMI Phase 2 safety study of a monoclonal anti-XI once-a-month injectable anti-XI anticoagulant, abelacimab.
Comments (0)
Anticoagulant Therapy
No comments here.